Literature DB >> 8303339

Life events, chronic difficulties and vulnerability factors preceding breast cancer.

S Geyer1.   

Abstract

This study deals with the association between life events, family history of mammary carcinoma and breast cancer. It was guided by a model consisting of events, family disposition and age at the side of the independent variables. In addition to these factors 'lack of social support' was introduced. The latter is conceptualized as a vulnerability factor capable of aggravating the impact of events without having an independent effect. There was no hypothesis on chronic difficulties, so this is exploratory. This research was conducted as a so-called 'limited prospective' design. Women with a suspicious breast lump were interviewed before surgery. After having confirmed the outcome of the surgery the sample was divided into a group with cancer and cases with a benign diagnosis. Women with gall stones were introduced as another control group. The interviews were performed along a semi-structured schedule, tape recorded and analyzed by using Brown and Harris' Life Events and Difficulties Scale. The analyses were made with 33 women with cancer, 59 with a benign tumor and 20 with gall stones. In the 'malignant' group the severest events was four times as high as in controls. All other degrees of threat were equally distributed over the groups. Chronic difficulties of the highest degree of severity also occur more often in the cancer group. They are not independent from events so that analyzing them separately is not useful. The rate of family history of breast cancer does not differ between the tumor groups, but is much lower in the gall stone patients. In the cancer group there is an association between this possibly hereditary factor and severe events, in the 'benign' group both are uncorrelated. The life event effect is explained in context of a higher illness susceptibility due to a hereditary disposition. For events occurring without it an explanation remains unclear.

Entities:  

Mesh:

Year:  1993        PMID: 8303339     DOI: 10.1016/0277-9536(93)90189-b

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Stress history and breast cancer recurrence.

Authors:  Oxana Palesh; Lisa D Butler; Cheryl Koopman; Janine Giese-Davis; Robert Carlson; David Spiegel
Journal:  J Psychosom Res       Date:  2007-08-02       Impact factor: 3.006

2.  Roles of Biopsychosocial Factors in the Development of Breast Cancer.

Authors:  Mine Özkan; Nazmiye Yıldırım; Rian Dişçi; Ahmet Serkan İlgün; Dauren Sarsenov; Gül Alço; Fatma Aktepe; Nesiba Kalyoncu; Filiz İzci; Derya Selamoğlu; Çetin Ordu; Kezban Nur Pilancı; Zeynep İyigün Erdoğan; Yeşim Eralp; Vahit Özmen
Journal:  Eur J Breast Health       Date:  2017-10-01

3.  Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population.

Authors:  Dorothee Noeres; Tjoung-Won Park-Simon; Jördis Grabow; Stefanie Sperlich; Heike Koch-Gießelmann; Jelena Jaunzeme; Siegfried Geyer
Journal:  Support Care Cancer       Date:  2013-02-16       Impact factor: 3.603

4.  Does the occurrence of adverse life events in patients with breast cancer lead to a change in illness behaviour?

Authors:  Siegfried Geyer; Dorothee Noeres; Mariya Mollova; Heike Sassmann; Alexandra Prochnow; Mechthild Neises
Journal:  Support Care Cancer       Date:  2008-07-29       Impact factor: 3.603

5.  Striking life events associated with primary breast cancer susceptibility in women: a meta-analysis study.

Authors:  Yan Lin; Changjun Wang; Ying Zhong; Xin Huang; Li Peng; Guangliang Shan; Ke Wang; Qiang Sun
Journal:  J Exp Clin Cancer Res       Date:  2013-08-13

6.  The Association between Adverse Events in the Last 5 Years and the Rate of Breast Cancer.

Authors:  Babak Rastegarimehr; Atefeh Zahedi; Parvin Yavari; Mohammad Hassan Lotfi; Moslem Taheri Soodejani
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.